Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FGPRN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,764
Award facts
- Contract value 100% obligated
- $10,763.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dupixent 300 mg/2 mL pens with a ceiling value of $10,763.64. This firm fixed-price delivery order, which is set to conclude on August 28, 2025, represents a single transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's SPE2DX indefinite delivery contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Dupixent (dupilumab) is a specialty biologic medication used for treating moderate-to-severe eczema, asthma, and other inflammatory conditions, reflecting the contractor's role in supplying specialized therapeutics across multiple therapeutic domains to the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FGPRN?
SPE2DB25FGPRN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FGPRN worth?
The government has obligated $10,764 on SPE2DB25FGPRN.
Is contract SPE2DB25FGPRN an order under another contract?
Yes. SPE2DB25FGPRN is a delivery order under SPE2DB24D2216, an indefinite delivery contract.
Was contract SPE2DB25FGPRN competed?
The extent of competition for SPE2DB25FGPRN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award